• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Quinazolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Benzodiazines Quinazolines

2-Chloroquinazoline-4-carbaldehyde (CAS No. 944903-02-0): A Versatile Building Block in Organic Synthesis

2-Chloroquinazoline-4-carbaldehyde (CAS No. 944903-02-0) is a highly valuable heterocyclic compound that has gained significant attention in pharmaceutical research and organic synthesis. As a quinazoline derivative, this compound serves as a crucial intermediate for the development of various biologically active molecules. The presence of both chloro and aldehyde functional groups makes it particularly reactive and useful for further chemical modifications.

The molecular structure of 2-Chloroquinazoline-4-carboxaldehyde features a fused bicyclic system consisting of a benzene ring and a pyrimidine ring, with the characteristic 4-formyl group and 2-chloro substitution. This unique arrangement contributes to its diverse reactivity patterns, making it an excellent precursor for synthesizing more complex quinazoline-based compounds. Researchers frequently utilize this building block in the preparation of potential drug candidates, especially in the development of kinase inhibitors and other therapeutic agents.

Recent studies highlight the growing importance of 2-Chloro-4-quinazolinecarbaldehyde in medicinal chemistry. Its derivatives show promising activity against various biological targets, aligning with current research trends in targeted drug discovery and personalized medicine. The compound's ability to undergo various condensation and nucleophilic substitution reactions makes it particularly valuable for creating libraries of potential bioactive molecules through combinatorial chemistry approaches.

From a synthetic chemistry perspective, 2-Cl-quinazoline-4-carbaldehyde offers multiple sites for chemical modification. The aldehyde group at position 4 can participate in condensation reactions to form Schiff bases or undergo reductive amination, while the chloro substituent at position 2 can be readily displaced by various nucleophiles. This dual reactivity has made the compound particularly popular in parallel synthesis and high-throughput screening applications.

The pharmaceutical industry has shown increasing interest in quinazoline-4-carbaldehyde derivatives due to their potential applications in developing treatments for various conditions. Current research focuses on their use as precursors for anticancer agents, anti-inflammatory compounds, and central nervous system modulators. These applications align with trending healthcare topics such as precision oncology and neurodegenerative disease treatment.

In material science applications, 2-Chloroquinazoline-4-aldehyde has demonstrated utility in the synthesis of organic electronic materials. The planar conjugated system of the quinazoline core makes it suitable for developing novel organic semiconductors and fluorescent materials, addressing current interests in flexible electronics and optoelectronic devices.

Quality control of 2-Chloroquinazoline-4-carboxaldehyde typically involves analytical techniques such as HPLC, NMR spectroscopy, and mass spectrometry. The compound generally appears as a pale yellow to off-white crystalline powder with high purity standards required for pharmaceutical applications. Proper storage conditions include protection from light and moisture at controlled room temperature to maintain stability.

From a commercial perspective, the demand for 2-Cl-quinazolinecarbaldehyde has been steadily increasing, particularly from contract research organizations and academic institutions engaged in drug discovery programs. Suppliers typically offer this compound in various quantities, with custom synthesis options available for specialized research needs. Current market trends show growing interest in high-purity heterocyclic building blocks like this one for fragment-based drug design.

Environmental and safety considerations for handling 2-Chloroquinazoline-4-carbaldehyde include standard laboratory precautions. While not classified as highly hazardous, proper personal protective equipment should be used when working with this compound. Researchers should consult the material safety data sheet (MSDS) for specific handling instructions and disposal guidelines.

The future outlook for 2-Chloro-4-formylquinazoline appears promising, with ongoing research exploring novel synthetic applications and biological activities. As the pharmaceutical industry continues to focus on small molecule therapeutics and kinase-targeted drugs, this compound is likely to maintain its importance as a versatile synthetic intermediate. Recent patent literature indicates growing intellectual property activity around quinazoline derivatives, suggesting sustained commercial interest in this chemical class.

For researchers working with 2-Chloroquinazoline-4-carbaldehyde, several key considerations should be noted. The compound's reactivity makes it suitable for various coupling reactions, while its stability allows for relatively straightforward storage and handling. Current best practices in synthetic chemistry recommend this building block for constructing diverse molecular architectures through efficient, modular approaches.

In conclusion, 2-Chloroquinazoline-4-carbaldehyde (CAS No. 944903-02-0) represents an important tool in modern organic and medicinal chemistry. Its unique structural features and versatile reactivity profile continue to make it valuable for pharmaceutical research, material science applications, and chemical biology studies. As research trends evolve toward more targeted therapeutic approaches, the significance of such specialized building blocks is expected to grow accordingly.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)